XML 71 R11.htm IDEA: XBRL DOCUMENT v2.4.1.9
Derivative Financial Instruments
6 Months Ended
May 01, 2015
Derivative Instruments And Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments


Note 6 – Derivative Financial Instruments

The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and interest rate swap contracts for the purpose of minimizing exposure to changes in foreign currency exchange rates on business transactions and interest rates, respectively.  The Company’s policy is to execute such instruments with banks the Company believes to be creditworthy and not to enter into derivative financial instruments for speculative purposes.  These derivative financial instruments do not subject the Company to undue risk, as gains and losses on these instruments generally offset gains and losses on the underlying assets, liabilities, or anticipated transactions that are being hedged.

All derivative financial instruments are recorded at fair value in the Consolidated Balance Sheet.  For a derivative that has not been designated as an accounting hedge, the change in the fair value is recognized immediately through earnings.  For a derivative that has been designated as an accounting hedge of an existing asset or liability (a fair value hedge), the change in the fair value of both the derivative and underlying asset or liability is recognized immediately through earnings.  For a derivative designated as an accounting hedge of an anticipated transaction (a cash flow hedge), the change in the fair value is recorded on the Consolidated Balance Sheet in Accumulated Other Comprehensive Income (AOCI) to the extent the derivative is effective in mitigating the exposure related to the anticipated transaction.  The change in the fair value related to the ineffective portion of the hedge, if any, is immediately recognized in earnings.  The amount recorded within AOCI is reclassified into earnings in the same period during which the underlying hedged transaction affects earnings.

The fair value of derivative instruments are presented on a gross basis, as the Company does not have any derivative contracts which are subject to master netting arrangements.  At May 1, 2015, and October 31, 2014, the Company did not have any hedges with credit-risk-related contingent features or that required the posting of collateral.  The cash flows from derivative contracts are recorded in operating activities in the Consolidated Statement of Cash Flows.

Foreign Currency Forward Exchange Contracts

The Company transacts business in various foreign currencies, which subjects the Company’s cash flows and earnings to exposure related to changes in foreign currency exchange rates.  These exposures arise primarily from purchases or sales of products and services from third parties.  Foreign currency forward exchange contracts provide for the purchase or sale of foreign currencies at specified future dates at specified exchange rates, and are used to offset changes in the fair value of certain assets or liabilities or forecasted cash flows resulting from transactions denominated in foreign currencies.  At May 1, 2015, and October 31, 2014, the Company had outstanding foreign currency forward exchange contracts principally to sell U.S. dollars with notional amounts of $374.2 million and $396.2 million, respectively.  These notional values consist primarily of contracts for the European euro, British pound sterling and Canadian dollar, and are stated in U.S. dollar equivalents at spot exchange rates at the respective dates.

Interest Rate Swaps

The Company manages its exposure to interest rate risk by maintaining an appropriate mix of fixed and variable rate debt, which over time should moderate the costs of debt financing.  When considered necessary, the Company may use financial instruments in the form of interest rate swaps to help meet this objective.

Embedded Derivative Instruments

The Company’s embedded derivatives are the result of entering into sales or purchase contracts that are denominated in a currency other than the Company’s functional currency or the supplier’s or customer’s functional currency.

Net Investment Hedge

In April 2015, the Company issued €330.0 million in 3.625% Senior Notes due April 2023 (2023 Notes) and requiring semi-annual interest payment in April and October each year until maturity.  The Company designated the 2023 Notes a hedge of the investment of certain foreign business units.  The foreign currency gain or loss that is effective as a hedge is reported as a component of other comprehensive income (loss) in shareholders’ equity.  To the extent that this hedge is ineffective, the foreign currency gain or loss is recorded in earnings.  There was no ineffectiveness since inception of the hedge.  The Company also designated the accrued interest on the 2023 Notes as a net investment hedge.

In July 2011, the Company entered into a Euro Term Loan for €125.0 million under the secured credit facility.  The Company designated the Euro Term Loan a hedge of the investment in a certain French business unit.  The foreign currency gain or loss that is effective as a hedge is reported as a component of other comprehensive income (loss) in shareholders’ equity.  To the extent that this hedge is ineffective, the foreign currency gain or loss is recorded in earnings.  There was no ineffectiveness since inception of the hedge.  On June 30, 2014, the Company paid off the remaining balance of the Euro Term Loan.  As a result, the Company recorded a net loss of $0.5 million on extinguishment of debt.


Fair Value of Derivative Instruments

Fair value of derivative instruments in the Consolidated Balance Sheet at May 1, 2015, and October 31, 2014, consisted of:

 

In Thousands

 

 

Fair Value

 

 

 

 

 

May 1,

 

 

October 31,

 

 

 

Classification

 

2015

 

 

2014

 

 

Foreign Currency Forward Exchange Contracts:

 

 

 

 

 

 

 

 

 

 

 

Other current assets

 

$

2,267

 

 

$

1,052

 

 

 

Other assets

 

 

651

 

 

 

53

 

 

 

Accrued liabilities

 

 

20,983

 

 

 

15,490

 

 

 

Other liabilities

 

 

5,429

 

 

 

3,290

 

 

 

 

 

 

 

 

 

 

 

 

 

Embedded Derivative Instruments:

 

 

 

 

 

 

 

 

 

 

 

Other current assets

 

$

541

 

 

$

296

 

 

 

Other assets

 

 

3,106

 

 

 

2,055

 

 

 

Accrued liabilities

 

 

105

 

 

 

15

 

 

 

Other liabilities

 

 

1,023

 

 

 

-

 

 

 

The effect of derivative instruments on the Consolidated Statement of Operations and Comprehensive Income (Loss) for the three and six month periods ended May 1, 2015, and May 2, 2014, consisted of:

Fair Value Hedges

We recognized the following gains (losses) on contracts designated as fair value hedges:

 

In Thousands

 

Three Months Ended

 

 

Six Months Ended

 

 

Gain (Loss)

 

May 1,

 

 

May 2,

 

 

May 1,

 

 

May 2,

 

 

 

 

2015

 

 

2014

 

 

2015

 

 

2014

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Embedded derivatives:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Recognized in sales

 

$

(5,230

)

 

$

(1,881

)

 

$

654

 

 

$

866

 

 

 

Cash Flow Hedges

We recognized the following gains (losses) on contracts designated as cash flow hedges:

 

In Thousands

 

Three Months Ended

 

 

Six Months Ended

 

 

Gain (Loss)

 

May 1,

 

 

May 2,

 

 

May 1,

 

 

May 2,

 

 

 

 

2015

 

 

2014

 

 

2015

 

 

2014

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward exchange contracts:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Recognized in AOCI (effective portion)

 

$

24,588

 

 

$

9,034

 

 

$

7,780

 

 

$

(2,735

)

 

Reclassified from AOCI into sales

 

 

(8,627

)

 

 

(2,242

)

 

 

(13,408

)

 

 

(2,741

)

 

 

Net Investment Hedges

We recognized the following gains (losses) on contracts designated as net investment hedges:

 

In Thousands

 

Three Months Ended

 

 

Six Months Ended

 

 

Gain (Loss)

 

May 1,

 

 

May 2,

 

 

May 1,

 

 

May 2,

 

 

 

 

2015

 

 

2014

 

 

2015

 

 

2014

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Euro Term Loan:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Recognized in AOCI

 

$

-

 

 

$

(556

)

 

$

-

 

 

$

(28

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2023 Notes:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Recognized in AOCI

 

$

(13,035

)

 

$

-

 

 

$

(13,035

)

 

$

-

 

 

 

During the first six months of fiscal 2015 and 2014, the Company recorded a loss of $1.8 million and a gain of $0.8 million, respectively, on foreign currency forward exchange contracts that have not been designated as accounting hedges.  These foreign currency exchange gains (losses) are included in selling, general and administrative expense.

There was no significant impact to the Company’s earnings related to the ineffective portion of any hedging instruments during the first six months of fiscal 2015 and 2014.  In addition, there was no significant impact to the Company’s earnings when a hedged firm commitment no longer qualified as a fair value hedge or when a hedged forecasted transaction no longer qualified as a cash flow hedge during the first six months of fiscal 2015 and 2014.

Amounts included in AOCI are reclassified into earnings when the hedged transaction settles.  The Company expects to reclassify approximately $15.9 million of net loss into earnings over the next 12 months.  The $15.9 million loss will reduce the Company’s U.S.-dollar-denominated sales covered by qualified forward contracts to the forward rate when the Company entered into the forward contracts.  The maximum duration of the Company’s foreign currency cash flow hedge contracts at May 1, 2015, is 24 months.